Late-onset neonatal sepsis: recent developments

Y Dong, CP Speer - Archives of Disease in Childhood-Fetal and …, 2015 - fn.bmj.com
The incidence of neonatal late-onset sepsis (LOS) is inversely related to the degree of
maturity and varies geographically from 0.61% to 14.2% among hospitalised newborns …

[PDF][PDF] Neonatal sepsis

IO Odabasi, A Bulbul - Şişli Etfal Hastanesi Tip Bülteni, 2020 - jag.journalagent.com
Neonatal sepsis is associated with severe morbidity and mortality in the neonatal period.
Clinical manifestations range from subclinical infection to severe local or systemic infection …

Characterisation and antimicrobial resistance of sepsis pathogens in neonates born in tertiary care centres in Delhi, India: a cohort study

S Chaurasia, M Jeeva Sankar, R Agarwal, CP Yadav… - Lancet, 2016 - repository.ias.ac.in
Background: Sepsis is one of the most common causes of neonatal deaths globally. Most
sepsis-related deaths occur in low-income and middle-income countries, where the …

Potential biomarkers for effective screening of neonatal sepsis infections: An overview

N Chauhan, S Tiwari, U Jain - Microbial pathogenesis, 2017 - Elsevier
Neonatal sepsis, a clinical disorder developed by bacterial blood stream infections (BSI) in
neonates, is one of the serious global public health problems that must be addressed. More …

Neonatal sepsis

M Ershad, A Mostafa, M Dela Cruz… - Current emergency and …, 2019 - Springer
Abstract Purpose of Review Neonatal sepsis is a diagnosis made in infants less than 28
days of life and consists of a clinical syndrome that may include systemic signs of infection …

Relevance of biomarkers currently in use or research for practical diagnosis approach of neonatal early-onset sepsis

MA Hincu, GI Zonda, GD Stanciu, D Nemescu… - Children, 2020 - mdpi.com
Neonatal early-onset sepsis (EOS) is defined as an invasive infection that occurs in the first
72 h of life. The incidence of EOS varies from 0.5–2% live births in developed countries, up …

Multidrug-resistant sepsis: A critical healthcare challenge

NR Kumar, TA Balraj, SN Kempegowda, A Prashant - Antibiotics, 2024 - mdpi.com
Sepsis globally accounts for an alarming annual toll of 48.9 million cases, resulting in 11
million deaths, and inflicts an economic burden of approximately USD 38 billion on the …

Late-onset neonatal sepsis—a 10-year review from North Queensland, Australia

H Gowda, R Norton, A White… - The Pediatric infectious …, 2017 - journals.lww.com
Objective: Late-onset sepsis (LOS) in neonates contributes significantly to both morbidity
and mortality. To determine the incidence of LOS, risk factors for disease and the impact on …

Emerging threat of multidrug resistant pathogens from neonatal sepsis

H Zou, X Jia, X He, Y Su, L Zhou, Y Shen… - Frontiers in Cellular …, 2021 - frontiersin.org
Multidrug-resistant (MDR) pathogens are responsible for a substantial burden of morbidity
and mortality from neonatal sepsis; however, data on these sepsis-related pathogens …

[PDF][PDF] Blood culture proven early onset sepsis and late onset sepsis in very-low-birth-weight infants in Korea

SM Lee, M Chang, KS Kim - Journal of Korean medical …, 2015 - synapse.koreamed.org
Neonatal sepsis remains one of the most important causes of death and co-morbidity in very-
low-birth-weight (VLBW) infants. The aim of this study was to determine the current …